Genelux Corporation
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GNLX and other ETFs, options, and stocks.About GNLX
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry.
CEOThomas D. Zindrick
CEOThomas D. Zindrick
Employees24
Employees24
HeadquartersWestlake Village, California
HeadquartersWestlake Village, California
Founded2001
Founded2001
Employees24
Employees24
GNLX Key Statistics
Market cap156.39M
Market cap156.39M
Price-Earnings ratio-4.64
Price-Earnings ratio-4.64
Dividend yield—
Dividend yield—
Average volume138.40K
Average volume138.40K
High today$4.42
High today$4.42
Low today$4.08
Low today$4.08
Open price$4.35
Open price$4.35
Volume100.58K
Volume100.58K
52 Week high$8.54
52 Week high$8.54
52 Week low$1.99
52 Week low$1.99
Stock Snapshot
The current Genelux Corporation(GNLX) stock price is $4.16, with a market capitalization of 156.39M. The stock trades at a price-to-earnings (P/E) ratio of -4.64.
On 2025-12-16, Genelux Corporation(GNLX) stock traded between a low of $4.08 and a high of $4.42. Shares are currently priced at $4.16, which is +2.0% above the low and -5.9% below the high.
The Genelux Corporation(GNLX)'s current trading volume is 100.58K, compared to an average daily volume of 138.4K.
During the past year, Genelux Corporation(GNLX) stock moved between $1.99 at its lowest and $8.54 at its peak.
During the past year, Genelux Corporation(GNLX) stock moved between $1.99 at its lowest and $8.54 at its peak.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own GNLX. This list is generated using Robinhood data, and it’s not a recommendation.